Vasoactive intestinal peptide overexpression mediated by lentivirus attenuates lipopolysaccharide-induced acute lung injury in mice by inhibiting inflammation-Reference-Cited by-同舟云学术

Vasoactive intestinal peptide overexpression mediated by lentivirus attenuates lipopolysaccharide-induced acute lung injury in mice by inhibiting inflammation

Published:2018-05 Issue: Volume:97 Page:8-15
ISSN:0161-5890
Container-title:Molecular Immunology
language:en
Short-container-title:Molecular Immunology

Author:

Sun Guo-Ying,Yang Hui-Hui,Guan Xin-Xin,Zhong Wen-Jing,Liu Yong-Ping,Du Ming-Yuan,Luo Xiao-Qin,Zhou Yong,Guan Cha-Xiang^ORCID

Funder

National Natural Science Foundation of China

Open-end fund of the valuable and precision instruments of Central South University

Research Foundation of Education Bureau of Hunan Province

Postdoctoral Science Foundation of Central South University

Publisher

Elsevier BV

Subject

Molecular Biology,Immunology

Reference48 articles.

1. Involvement of endothelial NO in the dilator effect of VIP on rat isolated pulmonary artery;Anaid;Regul. Pept.,2007

2. Vasoactive intestinal peptide (VIP) differentially affects inflammatory immune responses in human monocytes infected with viable Salmonella or stimulated with LPS;Askar;Peptides,2015

3. Conjugated Alpha-Alumina nanoparticle with vasoactive intestinal peptide as a Nano-drug in treatment of allergic asthma in mice;Athari;Eur. J. Pharmacol.,2016

4. Clinical potential of VIP by modified pharmaco-kinetics and delivery mechanisms;Burian;Endocr. Metab. Immune Disord. Drug Targets,2012

5. Acute lung injury: a clinical and molecular review;Butt;Arch. Pathol. Lab. Med.,2016

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sympathetic Neurotransmitter, VIP, Delays Intervertebral Disc Degeneration via FGF18/FGFR2‐Mediated Activation of Akt Signaling Pathway;Advanced Biology;2023-12-04

2. Mechanisms of NLRP3 inflammasome activation and the development of peptide inhibitors;Cytokine & Growth Factor Reviews;2023-12

3. The role of vasoactive intestinal peptide in pulmonary diseases;Life Sciences;2023-11

4. MEGF6 prevents sepsis-induced acute lung injury in mice;International Immunopharmacology;2023-10

5. Aloperine alleviates lipopolysaccharide-induced acute lung injury by inhibiting NLRP3 inflammasome activation;International Immunopharmacology;2023-07